Neurological & Psychological Disorders
News on research and diagnostic developments in neuroscience.
Ontario Brain Institute, EpiSign Partner on Rare Genetic Disorder Diagnosis
OBI's Center for Analytics and EpiSign will refine and validate EpiSign's machine-learning algorithm that analyzes a person's epigenome to detect rare genetic disorders.
In Brief This Week: 4baseCare, Flatiron Health, Primo Partners, Circular Genomics
News items for the week of March 17, 2025.
Novartis to Seek Approval for Intrathecal SMA Gene Therapy in Children, Young Adults in Early 2025
An intravenous form of the gene therapy is already approved and sold as Zolgensma in the US for patients less than 2 years of age.
MeiraGTx, Hologen Tackle CNS Disorders With AI Drug Development Joint Venture
Hologen is paying MeiraGTx $200 million upfront and committing $230 million to fund Hologen Neuro AI and a Parkinson's disease gene therapy.
NICE Still Not Recommending Leqembi, Kisunla for Alzheimer's in Updated Draft Guidance
NICE is seeking public comment on the updated draft guidances through March 27, with plans to issue final draft guidances in July.
Jan 15, 2025
Jan 6, 2025